APA (7th ed.) Citation

B, S., X, L., & H, J. (2024, August). Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up. Clinical, Cosmetic and Investigational Dermatology.

Chicago Style (17th ed.) Citation

B, Song, Liu X, and Jin H. "Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up." Clinical, Cosmetic and Investigational Dermatology Aug. 2024.

MLA (9th ed.) Citation

B, Song, et al. "Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up." Clinical, Cosmetic and Investigational Dermatology, Aug. 2024.